NEW
YORK, Dec. 16, 2022 /PRNewswire/ -- Jakubowitz
Law announces that a securities fraud class action lawsuit has
commenced on behalf of shareholders of Eiger BioPharmaceuticals,
Inc. (NASDAQ: EIGR).
To receive updates on the lawsuit, fill out the
form:
https://claimyourloss.com/securities/eiger-biopharmaceuticals-class-action-loss-submission-form/?id=34650&from=4
The lawsuit seeks to recover losses for shareholders who
purchased Eiger between March 10,
2021 and October 4, 2022.
Shareholders interested in acting as a lead plaintiff
representing the class of wronged shareholders have until
January 9, 2023 to petition
the court. Your ability to share in any recovery doesn't require
that you serve as a lead plaintiff.
According to a filed complaint, Eiger BioPharmaceuticals, Inc.
issued materially false and/or misleading statements and/or failed
to disclose that: (i) defendants overstated Eiger's clinical and
regulatory drug development expertise; (ii) defendants failed to
properly assess, and/or ignored issues with, the design of the
TOGETHER study and its ability to support the Emergency Use
Authorization ("EUA") for the Company's product candidate,
peginterferon lambda ; (iii) there were issues with the conduct of
the TOGETHER study and/or the TOGETHER study was not properly
designed for the peginterferon lambda EUA in the current context of
the pandemic; (iv) as a result, the U.S. Food and Drug
Administration was unlikely to approve the submission of a
peginterferon lambda EUA; (v) as a result of all the foregoing,
peginterferon lambda's regulatory and commercial prospects for the
treatment of COVID-19 were overstated; and (vi) as a result, the
Company's public statements were materially false and misleading at
all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for
shareholders who have been the victim of securities fraud. Attorney
advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original
content:https://www.prnewswire.com/news-releases/eigr-shareholder-alert-jakubowitz-law-reminds-eiger-shareholders-of-a-lead-plaintiff-deadline-of-january-9-2023-301704968.html
SOURCE Jakubowitz Law